InsidersTradesSigma
NextCell Pharma AB Stock: price and directors' dealings · Finland · FIN-FSA
Follow the NextCell Pharma AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, NextCell Pharma AB has logged 0 insider filings. Market capitalisation: €109.7m. The full history is openly available.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Declarations0 total
No declarations found
0 of 0 declarations
About NextCell Pharma AB
NextCell Pharma AB is a Swedish biopharmaceutical company focused on developing cell therapies for the treatment of type 1 diabetes. It is listed on the Stockholm Stock Exchange (XSTO).